Studies of the neuropathological alterations seen in Alzheimer's Disease (AD) and the molecular and cellular changes underlying them have yielded a wealth of information regarding the etiology of this devastating disease. The combined studies outlined in Projects 1-3 will extend upon this existing knowledge with rigorous cell biological, molecular, biochemical, behavioral, and electrophysiological studies of neuronal cells in vitro and in several mouse models of AD. These studies have the potential to provide greater insight into the etiology of AD as well as to elucidate possible novel targets for AD therapy. The Scientific Core will be a center devoted to facilitating the experiments proposed in Projects 1-3 that require the use of primary neuronal and organotypic cultures, genetically modified animals, immunological reagents, and yeast- reconstituted y-secretase. The existence of this centralized facility will ensure that the experiments outlined in Projects 1-3 will be completed in the most timely and cost-effective manner. Many of the studies proposed in this Program Project Grant will require the use of high-quality neuronal cultures to validate initial findings from transformed cell lines.
In Specific Aim I, the Core will be responsible for performing the routine tasks involved in the preparation of primary neuronal and organotypic cultures needed by Projects 1-3. As all of the findings of Projects 1-3 will ultimately be validated and tested in intact animals, the experiments outlined in these Projects will also require the breeding and maintenance of genetically modified animals. Thus the breeding and maintenance of transgenic mice is Specific Aim II of the Core. In order to aid in the characterization of new protein-protein interactions, protein localization, and protein phosphorylation, the Scientific Core will be a keysource of new polyclonal antibodies, including phosphorylation state- specific antibodies, as described in Specific Aim III. Finally, the reconstitution of y-secretaseactivity in the simple eukaryote P. pastoris for genetic manipulation and screening is Specific Aim IV.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG009464-18
Application #
7795011
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2009-02-01
Budget End
2010-01-31
Support Year
18
Fiscal Year
2009
Total Cost
$454,559
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Bettayeb, Karima; Hooli, Basaraj V; Parrado, Antonio R et al. (2016) Relevance of the COPI complex for Alzheimer's disease progression in vivo. Proc Natl Acad Sci U S A 113:5418-23
Bettayeb, Karima; Chang, Jerry C; Luo, Wenjie et al. (2016) ?-COP modulates A? peptide formation via retrograde trafficking of APP. Proc Natl Acad Sci U S A 113:5412-7
Liebmann, Thomas; Renier, Nicolas; Bettayeb, Karima et al. (2016) Three-Dimensional Study of Alzheimer's Disease Hallmarks Using the iDISCO Clearing Method. Cell Rep 16:1138-1152
Ceglia, Ilaria; Reitz, Christiane; Gresack, Jodi et al. (2015) APP intracellular domain-WAVE1 pathway reduces amyloid-? production. Nat Med 21:1054-9
Tian, Yuan; Chang, Jerry C; Greengard, Paul et al. (2014) The convergence of endosomal and autophagosomal pathways: implications for APP-CTF degradation. Autophagy 10:694-6
Chiba, Kyoko; Araseki, Masahiko; Nozawa, Keisuke et al. (2014) Quantitative analysis of APP axonal transport in neurons: role of JIP1 in enhanced APP anterograde transport. Mol Biol Cell 25:3569-80
Hochard, Arnaud; Oumata, Nassima; Bettayeb, Karima et al. (2013) Aftins increase amyloid-?42, lower amyloid-?38, and do not alter amyloid-?40 extracellular production in vitro: toward a chemical model of Alzheimer's disease? J Alzheimers Dis 35:107-20
Tian, Yuan; Chang, Jerry C; Fan, Emily Y et al. (2013) Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy. Proc Natl Acad Sci U S A 110:17071-6
Oh, Yong-Seok; Gao, Pu; Lee, Ko-Woon et al. (2013) SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. Cell 152:831-43
Bettayeb, Karima; Oumata, Nassima; Zhang, Yuanyuan et al. (2012) Small-molecule inducers of Aýý-42 peptide production share a common mechanism of action. FASEB J 26:5115-23

Showing the most recent 10 out of 115 publications